Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?
Introduction: The use of lifelong antiretroviral therapy (ART) results in increased costs of care; the ability to finance and control sustained costs of ART needs to be discussed. Approach: The Southern Alberta Clinic initiated a practical cost savings approach that switched select patients from a b...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-01-01
|
Series: | Journal of the International Association of Providers of AIDS Care |
Online Access: | https://doi.org/10.1177/2325958218822304 |
_version_ | 1818317348963090432 |
---|---|
author | Hartmut Krentz PhD Shayna Campbell BSc John Gill MD |
author_facet | Hartmut Krentz PhD Shayna Campbell BSc John Gill MD |
author_sort | Hartmut Krentz PhD |
collection | DOAJ |
description | Introduction: The use of lifelong antiretroviral therapy (ART) results in increased costs of care; the ability to finance and control sustained costs of ART needs to be discussed. Approach: The Southern Alberta Clinic initiated a practical cost savings approach that switched select patients from a branded ART to a less expensive generic variation. Our approach surveyed physicians and patients on their acceptance of switching and then launched a program asking patients if they would switch to generic variations for cost control purposes. Results: Our early findings found >50% of patients approached agreed to switch. We found no evidence of increased risk of viral breakthrough, resistance, side effects, or displeasure with generic drugs. Measured cost savings in the first year were >$1.1 million with annual projected savings of between $4.3 million and $2.6 million (in 2017 Cdn$). Conclusion: Our approach can provide an option for controlling costs of HIV care without compromising quality. |
first_indexed | 2024-12-13T09:35:54Z |
format | Article |
id | doaj.art-3f0db9995d7748cb803e477963b06b75 |
institution | Directory Open Access Journal |
issn | 2325-9582 |
language | English |
last_indexed | 2024-12-13T09:35:54Z |
publishDate | 2019-01-01 |
publisher | SAGE Publishing |
record_format | Article |
series | Journal of the International Association of Providers of AIDS Care |
spelling | doaj.art-3f0db9995d7748cb803e477963b06b752022-12-21T23:52:21ZengSAGE PublishingJournal of the International Association of Providers of AIDS Care2325-95822019-01-011810.1177/2325958218822304Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?Hartmut Krentz PhD0Shayna Campbell BSc1John Gill MD2 Department of Medicine, University of Calgary, Calgary, Canada Southern Alberta Clinic, Calgary, Canada Department of Medicine, University of Calgary, Calgary, CanadaIntroduction: The use of lifelong antiretroviral therapy (ART) results in increased costs of care; the ability to finance and control sustained costs of ART needs to be discussed. Approach: The Southern Alberta Clinic initiated a practical cost savings approach that switched select patients from a branded ART to a less expensive generic variation. Our approach surveyed physicians and patients on their acceptance of switching and then launched a program asking patients if they would switch to generic variations for cost control purposes. Results: Our early findings found >50% of patients approached agreed to switch. We found no evidence of increased risk of viral breakthrough, resistance, side effects, or displeasure with generic drugs. Measured cost savings in the first year were >$1.1 million with annual projected savings of between $4.3 million and $2.6 million (in 2017 Cdn$). Conclusion: Our approach can provide an option for controlling costs of HIV care without compromising quality.https://doi.org/10.1177/2325958218822304 |
spellingShingle | Hartmut Krentz PhD Shayna Campbell BSc John Gill MD Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy? Journal of the International Association of Providers of AIDS Care |
title | Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy? |
title_full | Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy? |
title_fullStr | Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy? |
title_full_unstemmed | Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy? |
title_short | Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy? |
title_sort | desimplification of single tablet antiretroviral art regimens a practical cost savings strategy |
url | https://doi.org/10.1177/2325958218822304 |
work_keys_str_mv | AT hartmutkrentzphd desimplificationofsingletabletantiretroviralartregimensapracticalcostsavingsstrategy AT shaynacampbellbsc desimplificationofsingletabletantiretroviralartregimensapracticalcostsavingsstrategy AT johngillmd desimplificationofsingletabletantiretroviralartregimensapracticalcostsavingsstrategy |